Truncated MEK1 is required for transient activation of MAPK signalling in G2 phase cells

Tanya Pike1, Charlotte Widberg, Andrew Goodall

  • 1The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

Cellular Signalling
|March 26, 2013
PubMed

Insights

A novel truncated form of MEK1 (tMEK) acts as a feedback inhibitor in the MAP kinase pathway. This tMEK dampens ERK and p90RSK activation during G2/M phase, regulating cell cycle progression.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Signal Transduction

Background:

  • The canonical Raf-MEK-ERK MAP kinase cascade is crucial for cellular responses.
  • ERK activation is a primary endpoint, but its regulation, especially during cell cycle phases like G2, is complex.

Purpose of the Study:

  • To investigate a novel signaling outcome of the MAP kinase pathway during G2 phase.
  • To elucidate the role of truncated MEK1 (tMEK) in regulating MAP kinase signaling and cell cycle progression.

Main Methods:

  • Stimulation of MAP kinase pathway using growth factors or phorbol esters during G2 phase.
  • Analysis of ERK and p90RSK activation dynamics.
  • Expression and functional analysis of recombinant MEK1 mutants, including catalytically inactive and phosphorylated forms.
  • Assessment of tMEK accumulation and its impact on signaling and mitosis.

Main Results:

  • MAP kinase pathway activation in G2 phase leads to transient ERK and p90RSK activation followed by suppression.
  • A novel truncated form of MEK1 (tMEK) is induced upon G2 phase MAP kinase activation.
  • Catalytically inactive but phosphorylated tMEK mutants inhibit ERK and p90RSK activation and delay mitosis.
  • Lack of MEK1 or tMEK accumulation abrogates feedback inhibition of ERK and p90RSK.

Conclusions:

  • tMEK is a novel output of the MAP kinase pathway, functioning as a negative feedback regulator.
  • tMEK dampens the magnitude and duration of MAP kinase signaling during G2/M phase.
  • This mechanism plays a role in controlling cell cycle progression by modulating ERK and p90RSK activity.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...